Published in Br J Pharmacol on February 01, 1973
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol (1975) 1.72
The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol (1979) 1.07
Effect of labetalol on the uptake of [3H]-(-)-noradrenaline into the isolated vas deferens of the rat. Br J Pharmacol (1978) 1.00
Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung. Br J Pharmacol (1976) 0.94
The fate of biogenic monoamines in perfused rabbit lung. Br J Pharmacol (1977) 0.79
Hypoxia impairs vasodilation in the lung. J Clin Invest (1981) 0.76
Proceedings: Calcium influx into single crustacean muscle fibres as measured with a glass scintillator probe. J Physiol (1975) 0.75
A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother (1957) 17.22
Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther (1953) 8.48
The release and fate of vaso-active hormones in the circulation. Br J Pharmacol (1969) 7.90
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation. J Physiol (1970) 2.26
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol (1970) 1.79
Effect of drugs on the accumulation and metabolism of extraneuronal norepinephrine in the rat heart. J Pharmacol Exp Ther (1967) 1.63
The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther (1969) 1.40
Effects of imipramine on the peripheral autonomic system. Arch Int Pharmacodyn Ther (1960) 1.38
METABOLISM OF VASOMOTOR AGENTS BY THE ISOLATED PERFUSED LUNG. J Thorac Cardiovasc Surg (1964) 1.25
Disappearance of catecholamines from the circulation. Nature (1968) 0.98
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol (1998) 7.22
Report on the questionnaire on the organization of pharmacology in Great Britian. Br J Pharmacol Chemother (1966) 3.77
Pharmacokinetic function of the pulmonary circulation. Physiol Rev (1974) 2.52
Metabolism of the angiotensins in isolated perfused tissues. Nature (1969) 1.91
Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol (1970) 1.79
The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine. Br J Pharmacol (1970) 1.63
Second report on the organization of pharmacology in Great Britain. Br J Pharmacol (1974) 1.57
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol (2006) 1.44
Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol (2000) 1.33
Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation. Br J Pharmacol (1978) 1.30
Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature (1968) 1.27
Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme. Nature (1970) 1.27
Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. Br J Pharmacol (1985) 1.14
Effects of cigarete smoke on metabolism of vasoactive hormones in rat isolated lungs [proceedings]. Br J Pharmacol (1978) 1.10
The inactivation of bradykinin in the pulmonary circulation of isolated lungs. Br J Pharmacol (1972) 1.07
The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol (1979) 1.07
Cellular and antiviral effects of halogenated deoxyribonucleosides. Ann N Y Acad Sci (1965) 1.00
Removal of 5-hydroxytryptamine by rat isolated lung. Br J Pharmacol (1970) 1.00
Effects of sulphasalazine on prostaglandin inactivation and synthesis in isolated lungs of guinea pig, rat and man. Eur J Pharmacol (1980) 0.99
Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors. Br J Pharmacol (1986) 0.99
Altered prostaglandin synthesis in isolated lungs of rats with streptozotocin-induced diabetes. Thromb Res (1982) 0.99
Differences in biological activation of arachidonic acid in perfused lungs from guinea pig, rat and man. Eur J Pharmacol (1980) 0.98
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol (2002) 0.98
Third Report on the Organization of Pharmacology in Great Britain. Br J Pharmacol (1986) 0.97
Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung. Br J Pharmacol (1976) 0.94
Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br J Pharmacol (1995) 0.94
Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur J Pharmacol (1995) 0.93
Metabolism and uptake of adenosine in rat isolated lung and its inhibition. Br J Pharmacol (1983) 0.93
Effects of cigarette smoke on the metabolism of vasoactive hormones in rat isolated lungs. Br J Pharmacol (1979) 0.92
Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br J Pharmacol (1996) 0.90
Uptake of beta-phenylethylamine in rat isolated lung. Biochem Pharmacol (1980) 0.89
The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. Br J Clin Pharmacol (1986) 0.89
Action of prostaglandin dehydrogenase inhibitors on prostaglandin uptake in rat isolated lung. Br J Pharmacol (1979) 0.88
Release of smooth muscle-contracting substances from isolated perfused lungs. Eur J Pharmacol (1976) 0.87
Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol (2007) 0.87
Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Life Sci (2007) 0.87
Release of spasmogenic substances induced by vasoactive amines from isolated lungs. Br J Pharmacol (1972) 0.87
Sequential changes in lung metabolism, permeability, and edema after ANTU. J Appl Physiol (1985) (1987) 0.87
Inflammatory responses induced by poly-L-arginine in rat lungs in vivo. Agents Actions (1993) 0.86
Decreased inactivation of prostaglandin E2 in isolated lungs from rats with alpha-naphthyl thiourea-induced pulmonary oedema. Biochem Pharmacol (1982) 0.86
Tryptamine receptors in rat pulmonary artery. Br J Pharmacol (1974) 0.86
Inactivation of monoamines by the lung. Ciba Found Symp (1980) 0.86
Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. Microcirculation (2005) 0.86
Uptake of E-type prostaglandins by rat isolated lung [proceedings]. J Physiol (1977) 0.85
Metabolism of vasoactive hormones in human isolated lung. Clin Sci (Lond) (1980) 0.85
Effect of the oestrous cycle and exogenous steroids on metabolism of 5-hydroxytryptamine by monoamine oxidase from rat lung [proceedings]. J Physiol (1978) 0.85
The bradykininase activities of extracts of dog lung. Br J Pharmacol (1973) 0.85
Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo. J Immunol (1996) 0.85
Phospholipases A2 and C of human lung; subcellular distribution and substrate selectivity. Biochim Biophys Acta (1989) 0.84
Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity. J Lipid Mediat Cell Signal (1994) 0.84
Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs. Br J Pharmacol (1977) 0.84
Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan. Neuropharmacology (2006) 0.83
Clinically-used dyes are inhibitors of prostaglandin E2 inactivation in rat isolated lung [proceedings]. Br J Pharmacol (1978) 0.83
PGI2 release from guinea-pig lungs: detection and bioassay [proceedings]. Br J Pharmacol (1978) 0.83
Characteristics of the angiotensin I converting enzyme from dog lung. Nat New Biol (1971) 0.82
Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice. J Biomed Mater Res B Appl Biomater (2007) 0.82
Celecoxib induces tolerance in a model of peripheral inflammatory pain in rats. Neuropharmacology (2010) 0.82
Inhibition of angiotensin I converting enzyme by venom peptides. Br J Pharmacol (1971) 0.82
Fate of arachidonic acid in guinea-pig isolated lungs [proceedings]. J Physiol (1978) 0.82
Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung. Biochem Pharmacol (1985) 0.82
Effect of pulmonary oedema induced by alpha-naphthylthiourea on synthesis of cyclo-oxygenase products in rat isolated lungs. Prostaglandins (1985) 0.81
Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung. Histochemistry (1974) 0.81
Metabolism of 14C-arachidonate in rat isolated lung. Prostaglandins (1980) 0.81
Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey. Ciba Found Symp (1980) 0.81
Metabolism of arachidonic acid and its endoperoxide (PGH2) to myotropic products in guinea-pig and rabbit isolated lungs. Br J Pharmacol (1980) 0.81
The fate of exogenous arachidonic acid in guinea-pig isolated lung. J Physiol (1979) 0.80
Effects of high oxygen tension on the metabolism of vasoactive hormones in isolated perfused rat lungs. Acta Physiol Scand (1981) 0.80
Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia. Life Sci (2010) 0.80
The inactivation of endogenous amines in lung. Agents Actions (1976) 0.80
Dual effects of Rho-kinase inhibitors on a rat model of inflammatory pain. Pain Res Manag (2014) 0.79
2,4-Diamino-6,7-dimethoxyquinazolines. 2. 2-(4-Carbamoylpiperidino) derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents. J Med Chem (1987) 0.79
Effects of halothane on pulmonary inactivation of noradrenaline and prostaglandin E2 in anaesthetized dogs. Clin Sci Mol Med (1976) 0.79
The fate of adenine nucleotides in the pulmonary circulation of isolated lung. Q J Exp Physiol (1983) 0.79
Metabolism of beta-phenylethylamine in rat lung during the oestrous cycle [proceedings]. J Physiol (1978) 0.79
Effects of Ph CL 28A on eicosanoid synthesis in rat isolated hearts. Prostaglandins (1991) 0.78
Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system. Pharmacology (2012) 0.78
Bronchodilator and tracheal relaxant effects of potassium channel openers in the guinea-pig. Br J Pharmacol (1989) 0.78
Biosynthesis of prostaglandins and thromboxanes in lung. Bull Eur Physiopathol Respir (1981) 0.78
Metabolism of arachidonic acid and its endoperoxide prostaglandin H2 in isolated lungs from guinea-pigs and rabbits [proceedings]. J Physiol (1979) 0.78
A study of the muscarinic receptor subtype mediating mucus secretion in the cat trachea in vitro. Pulm Pharmacol (1989) 0.78
Cationic factors affecting phospholipase activities from human lung. Br J Pharmacol (1990) 0.78
Exposure to oxygen inhibits metabolism of vasoactive hormones in rat isolated lung [proceedings]. J Physiol (1979) 0.78
Metabolism of angiotensin and bradykinin in rat isolated lungs during the oestrous cycle [proceedings]. J Physiol (1979) 0.77
Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse. Int J Exp Pathol (1992) 0.77
Synthesis and catabolism of cyclo-oxygenase products. Br Med Bull (1983) 0.77
Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice. Br J Cancer (1992) 0.77
Inhibition by clinically used dyes of prostaglandin inactivation in rat and human lung. Br J Pharmacol (1981) 0.77
Effect of streptozotocin-induced diabetes on the metabolism of ADP, AMP and adenosine in the pulmonary circulation of rat isolated lung. Diabetologia (1983) 0.76
Impairment in connective tissue mast cells degranulation in spontaneously hypertensive rats: stimulus dependent resistance. Br J Pharmacol (1998) 0.76
Effects of the oestrous cycle and exogenous ovarian steroids on metabolism of beta-phenylethylamine in rat lung. Br J Pharmacol (1979) 0.76
Effects of oestrous cycle and exogenous ovarian steroids on 5-hydroxytryptamine metabolism in rat lung. J Physiol (1979) 0.76